These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21195876)

  • 1. Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.
    Udayakumar TS; Stoyanova R; Hachem P; Ahmed MM; Pollack A
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):549-58. PubMed ID: 21195876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
    Udayakumar TS; Hachem P; Ahmed MM; Agrawal S; Pollack A
    Mol Cancer Res; 2008 Nov; 6(11):1742-54. PubMed ID: 19010821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.
    Nguyen KH; Hachem P; Khor LY; Salem N; Hunt KK; Calkins PR; Pollack A
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):238-46. PubMed ID: 15993550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
    Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy.
    Cowen D; Salem N; Ashoori F; Meyn R; Meistrich ML; Roth JA; Pollack A
    Clin Cancer Res; 2000 Nov; 6(11):4402-8. PubMed ID: 11106260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.
    Stoyanova R; Hachem P; Hensley H; Khor LY; Mu Z; Hammond ME; Agrawal S; Pollack A
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1151-60. PubMed ID: 17637390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKA knockdown enhances cell killing in response to radiation and androgen deprivation.
    Hensley HH; Hannoun-Levi JM; Hachem P; Mu Z; Stoyanova R; Khor LY; Agrawal S; Pollack A
    Int J Cancer; 2011 Feb; 128(4):962-73. PubMed ID: 20960462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of prostate cancer radiosensitization by androgen deprivation.
    Pollack A; Salem N; Ashoori F; Hachem P; Sangha M; von Eschenbach AC; Meistrich ML
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1002-7. PubMed ID: 11704324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.
    Wei WY; Yan LH; Wang XT; Li L; Cao WL; Zhang XS; Zhan ZX; Yu H; Xie YB; Xiao Q
    World J Gastroenterol; 2015 Jan; 21(2):491-501. PubMed ID: 25593464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.
    Li X; Marani M; Yu J; Nan B; Roth JA; Kagawa S; Fang B; Denner L; Marcelli M
    Cancer Res; 2001 Jan; 61(1):186-91. PubMed ID: 11196158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models.
    Zhang Z; Wang H; Prasad G; Li M; Yu D; Bonner JA; Agrawal S; Zhang R
    Clin Cancer Res; 2004 Feb; 10(4):1263-73. PubMed ID: 14977824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro and in vivo inhibitory effect of Ad-ING4 gene on proliferation of human prostate cancer PC-3 cells].
    Yang HC; Sheng WH; Xie YF; Miao JC; Wei WX; Yang JC
    Ai Zheng; 2009 Nov; 28(11):1149-57. PubMed ID: 19895734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer.
    Brooks C; Sheu T; Bridges K; Mason K; Kuban D; Mathew P; Meyn R
    Radiat Oncol; 2012 Sep; 7():154. PubMed ID: 22967802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer.
    Arafat W; Zhou T; Naoum GE; Buchsbaum DJ
    J Egypt Natl Canc Inst; 2015 Dec; 27(4):205-15. PubMed ID: 26385392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.
    Mu Z; Hachem P; Hensley H; Stoyanova R; Kwon HW; Hanlon AL; Agrawal S; Pollack A
    Prostate; 2008 May; 68(6):599-609. PubMed ID: 18196567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA
    Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination.
    Mu Z; Hachem P; Agrawal S; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):336-43. PubMed ID: 14751501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.